Flenozine 10 Tablet

Introduction

Flenozine is a prescription medication that contains the active ingredient Flunarizine. Flunarizine is a calcium channel blocker that is used to treat certain conditions related to the brain and blood vessels.

Uses

Flenozine is primarily prescribed for the prevention and treatment of migraines and vertigo. It helps reduce the frequency and severity of migraines, as well as the associated symptoms such as headache, nausea, and sensitivity to light and sound. Additionally, it can help alleviate symptoms of vertigo, including dizziness, spinning sensations, and balance problems.

Dosage and Administration

The dosage of Flenozine may vary depending on the individual’s condition and response to treatment. Follow the instructions provided by your healthcare professional. Typically, the recommended starting dose for migraines is 5 mg per day, which may be increased to 10 mg per day if necessary. For vertigo, the usual starting dose is 10 mg per day, which may be adjusted as needed.

Flenozine should be taken orally with or without food, preferably at the same time each day. It is important not to crush or chew the tablet, as it is designed to be swallowed whole.

Mechanism of Action

Flunarizine, the active ingredient in Flenozine, works by blocking calcium channels in the brain and blood vessels. This helps to regulate the flow of calcium ions, which can reduce the hyperexcitability of nerve cells and prevent the narrowing of blood vessels. By doing so, Flunarizine helps to prevent migraines and manage symptoms of vertigo.

Side Effects

Common side effects may include drowsiness, dizziness, weight gain, and increased appetite. These side effects are usually mild and temporary, but if they persist or worsen, consult your healthcare professional.

Serious side effects are rare but may include movement disorders, depression, and Parkinsonism-like symptoms. If you experience any of these serious side effects or any other unusual symptoms, seek immediate medical attention.

Drug Interactions

Flenozine may interact with other medications, including certain antidepressants, antipsychotics, and medications that affect the central nervous system. Inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products, to avoid potential drug interactions.

Precautions

Before taking Flenozine, inform your healthcare professional about any existing medical conditions, including liver or kidney problems. This medication may not be suitable for individuals with a history of depression or movement disorders. Avoid alcohol while taking Flenozine, as it may increase the risk of side effects.

Storage

Patient Tips

• Take Flenozine exactly as prescribed by your healthcare professional. Do not adjust the dosage without consulting them.
• It may take some time for the medication to show its full effect. Be patient and continue taking it as directed.
• If you have any concerns or questions about the medication, do not hesitate to reach out to your healthcare professional.
• Keep a record of your migraine or vertigo symptoms to help track your progress and communicate with your healthcare professional.
• Avoid driving or operating heavy machinery if you experience drowsiness or dizziness while taking Flenozine.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to make up for a missed one.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Flunarizine (International database) (Drugs.com) [Accessed 24 Jun. 2024] (online) Available at:
• LactMed: Drugs and Lactation Database (National Library of Medicine) [Accessed 1 Jun. 2024] (online) Available at:
• Deligianni CI, Sacco S, Ekizoglu E, Uluduz D, Gil-Gouveia R, MaassenVanDenBrink A, Ornello R, Sanchez-Del-Rio M, Reuter U, Versijpt J, de Vries T, Hussain M, Zeraatkar D, Lampl C. European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizine. J Headache Pain. 2023 Sep 19;24(1):128. doi: 10.1186/s10194-023-01657-3. [Accessed 0 Jun. 2024] Available at:
• Inapsine Advanced Patient Information Consumer Information (Micromedex) (Drugs.com) [Accessed 28 Jun. 2024] (online) Available at: